Alfonso Zambon

This inventor holds 15 USPTO granted patents, plus 2 CIPO patents and 5 EPO patents. Top assignees: Cancer Research Technology Limited, Institute of Cancer Research: Royal Cancer Hospital (the), The Institute of Cancer Research: Royal Cancer Hospital. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alfonso Zambon. Retrieved from https://idiyas.com/inventor/alfonso-zambon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 26.7

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 6.3

ph-index = 7

Forward Citations = 85(Granted Patents)

Location History:

Surrey, GB (2014)
Sutton, GB (2012 - 2019)
Reggio Emilia, IT (2022)

Company Filing History:

14 out of 268

Cancer Research Technology Limited

patents

10 out of 13

Institute of Cancer Research: Royal Cancer Hospital (the)

patents

4 out of 54

The Institute of Cancer Research: Royal Cancer Hospital

patents

4. 1 out of 1

Institute of Cancer Research: Royal Cancer Hosp. (the)

patent

5. 1 out of 1

Oxy Scientific Limited

patent

where one patent can have more than one assignee

Years Active: 2012-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11325915 - Lysyl oxidase inhibitors (2022-05-10),

2. 10167282 - 1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer (2019-01-01),

3. 10100053 - Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-b]pyrazin-3-one derivatives (2018-10-16),

4. 9820976 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2017-11-21),

5. 9725447 - 1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer (2017-08-08),

6. 9708317 - Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivatives (2017-07-18),

7. 9540372 - Pyrido[2,3-b]pyrazin-8-substituted compounds and their use (2017-01-10),

8. 9439893 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2016-09-13),

9. 9155737 - Pyrido[2,3-B]pyrazin-8-substituted compounds and their use (2015-10-13),

10. 9120789 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2015-09-01),

11. 8912191 - Pyrido[2,3-B]pyrazin-8-substituted compounds and their use (2014-12-16),

12. 8815896 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2014-08-26),

13. 8546387 - Pyrido[2,3-b]pyrazin-8-substituted compounds and their use (2013-10-01),

14. 8383816 - Aryl-quinolyl compounds and their use (2013-02-26),

15. 8198279 - Pyrido[2,3-b]pyrazin-8-substituted compounds and their use (2012-06-12),

Title: Alfonso Zambon: Pioneering Inventor from Sutton, GB

Introduction: Alfonso Zambon is a renowned inventor hailing from Sutton, Great Britain, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Alfonso Zambon holds several patents in the areas of renewable energy technologies, artificial intelligence, and sustainable materials, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Alfonso Zambon has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of inventions. His innovative spirit and dedication to creating solutions for complex problems have earned him recognition globally.

Collaborations: Throughout his career, Alfonso Zambon has collaborated with top universities, multinational corporations, and fellow inventors to bring his ideas to life. His ability to work across disciplines and industries has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Alfonso Zambon's passion for innovation, coupled with his technical expertise, has solidified his position as a trailblazer in the world of inventions. His work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.